Status:
RECRUITING
Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection
Lead Sponsor:
Ain Shams University
Conditions:
Breast Carcinoma
Eligibility:
FEMALE
30-50 years
Brief Summary
The aim of this study is to evaluate the added value of non-contrast abbreviated MRI protocol featuring ultra-high B value Diffusion Weighted Imaging to detect, characterize suspicious breast lesions ...
Eligibility Criteria
Inclusion
- • Women with suspicious breast mass (BIRADS 4a)
- High risk women (Positive family history)
- Women with suspicious axillary lymph nodes by Ultrasound
- Women with dense breasts coming for MRI imaging.
Exclusion
- • Contraindications to MRI
- Pacemaker, cochlear implant, claustrophobia, ocular implants
- Contraindications to contrast administration:
- Elevated kidney functions
- Women who haven't undergone reliable Mammogram \& Ultrasound
- Women with prior treatment or intervention (e.g. biopsy)
- Patients' refusal.
Key Trial Info
Start Date :
May 10 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT06970288
Start Date
May 10 2025
End Date
December 30 2026
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Abbasia, Egypt